Long-Term Effects on the Lipidome of Acute Coronary Syndrome Patients
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
NV18-08-00149
Ministry of Health
00023736
Ministry of Health
A1_FPBT_2021_001
University of Chemistry and Technology
PubMed
35208199
PubMed Central
PMC8878326
DOI
10.3390/metabo12020124
PII: metabo12020124
Knihovny.cz E-zdroje
- Klíčová slova
- acute coronary syndrome, high resolution mass spectrometry, lipidomics, stroke,
- Publikační typ
- časopisecké články MeSH
Lipids modified by oxidative stress are key players in atherosclerosis progression. Superimposed thrombosis with subsequent closure of the coronary artery leads to the clinical manifestation of acute coronary syndrome (ACS). While several studies focusing on alterations in lipid metabolism in the acute phase have been conducted, no information is available on patients' lipidome alterations over longer time periods. In the current follow-up study, we analyzed plasma samples obtained from 17 patients three years after their ACS event (group AC). Originally, these patients were sampled 3-5 days after an index event (group B). Lipidome stability over time was studied by untargeted lipidomics using high performance liquid chromatography coupled to high resolution mass spectrometry (UHPLC-HRMS). Multi-dimensional statistics used for data processing indicated that plasmalogen lipids were the most prominent lipids separating the above patient groups and that they increased in the follow-up AC group. A similar trend was observed for lysophosphatidylethanolamine (LPE) and phosphatidylethanolamine (PE). The opposite trend was observed for two fatty acyls of hydroxy fatty acid (FAHFAs) lipids and free stearic acid. In addition, a decrease in the "classic" oxitadive stress marker, malondialdehyde (MDA), occurred during the follow-up period. Our findings present unique information about long-term lipidome changes in patients after ACS.
Zobrazit více v PubMed
Fan A., Wu X., Wu H., Li L., Huang R., Zhu Y., Qiu Y., Fu J., Ren J., Zhu C. Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL. PLoS ONE. 2014;9:e85337. doi: 10.1371/journal.pone.0085337. PubMed DOI PMC
Maiolino G., Rossitto G., Caielli P., Bisogni V., Rossi G.P., Calò L.A. The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts. Mediat. Inflamm. 2013;2013:714653. doi: 10.1155/2013/714653. PubMed DOI PMC
Giovanni D., Carlo P. Platelet Activation and Atherothrombosis. N. Engl. J. Med. 2007;357:2482–2494. PubMed
Malý M., Hajšl M., Bechyňská K., Kučerka O., Šrámek M., Suttnar J., Hlaváčková A., Hajšlová J., Kosek V. Lipidomic Analysis to Assess Oxidative Stress in Acute Coronary Syndrome and Acute Stroke Patients. Metabolites. 2021;11:412. doi: 10.3390/metabo11070412. PubMed DOI PMC
Mundra P., Barlow C.K., Nestel P.J., Barnes E.H., Kirby A., Thompson P., Sullivan D.R., Alshehry Z.H., Mellett N.A., Huynh K., et al. Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention. JCI Insight. 2018;3:e121326. doi: 10.1172/jci.insight.121326. PubMed DOI PMC
Park J.Y., Lee S.-H., Shin M.-J., Hwang G.-S. Alteration in Metabolic Signature and Lipid Metabolism in Patients with Angina Pectoris and Myocardial Infarction. PLoS ONE. 2015;10:e0135228. doi: 10.1371/journal.pone.0135228. PubMed DOI PMC
Toledo E., Wang D.D., Ruiz-Canela M., Clish C.B., Razquin C., Zheng Y., Guasch-Ferré M., Hruby A., Corella D., Gómez-Gracia E., et al. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. Am. J. Clin. Nutr. 2017;106:973–983. doi: 10.3945/ajcn.116.151159. PubMed DOI PMC
Koelmel J.P., Kroeger N.M., Ulmer C.Z., Bowden J.A., Patterson R.E., Cochran J.A., Beecher C.W.W., Garrett T.J., Yost R.A. LipidMatch: An automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinform. 2017;18:331. doi: 10.1186/s12859-017-1744-3. PubMed DOI PMC
Chen H., Wang Z.X., Qin M., Zhang B., Lin L., Ma Q.L., Liu C., Chen X.P., Li H.P., Lai W.H., et al. Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression. Front. Mol. Biosci. 2021;8:632950. doi: 10.3389/fmolb.2021.632950. PubMed DOI PMC
Oxidative Stress as a Reliable Biomarker of Carotid Plaque Instability: A Pilot Study